Medicare Enrolled

John Waas

Hematology & Oncology · Greensburg, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
400 OAKBROOK DR, Greensburg, PA 15601
7248341463
Registered in NPPES since 2006
NPI: 1093789489 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Waas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Waas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Waas

John Waas is a hematology & oncology specialist in Greensburg, PA, with 20 years of NPI registration. Based on federal Medicare data, Waas performed 3,040 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Waas received a total of $3,505 from 25 pharmaceutical and/or device companies across 47 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Waas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 20% volume in PA $3,505 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,040
Medicare services
Top 20% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, granisetron hydrochloride, 100 mcg 740 $0 $3
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
598 $0 $1
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
510 $8 $41
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
226 $21 $100
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
188 $92 $754
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
165 $10 $69
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
130 $21 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
88 $83 $237
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
68 $115 $319
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
61 $44 $223
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
47 $1 $4
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
44 $12 $69
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
44 $59 $213
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
35 $1 $6
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
34 $6 $39
Manual white blood cell count
A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present.
32 $4 $24
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $51 $158
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
14 $100 $388
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.6% high complexity
57.9% medium
26.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,505
Total received (2018-2024)
Avg $501/year across 7 years
Top 40% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
47
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$144
2023
$182
2022
$548
2021
$340
2020
$261
2019
$480
2018
$1,551

Payments by company (2024)

Merck Sharp & Dohme LLC
$118
Janssen Biotech, Inc.
$26
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$935
AstraZeneca Pharmaceuticals LP
$365
Celgene Corporation
$253
Merck Sharp & Dohme Corporation
$214
Pharmacyclics LLC, An AbbVie Company
$198
Blueprint Medicines Corporation
$183
Seagen Inc.
$165
Exelixis Inc.
$133
Lilly USA, LLC
$125
EISAI INC.
$122
Merck Sharp & Dohme LLC
$118
E.R. Squibb & Sons, L.L.C.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$88
Daiichi Sankyo Inc.
$78
Puma Biotechnology, Inc.
$76
Janssen Biotech, Inc.
$66
Astellas Pharma US Inc
$64
Incyte Corporation
$45
Genentech USA, Inc.
$44
Mirati Therapeutics, Inc.
$42
Clovis Oncology, Inc.
$25
TESARO, Inc.
$23
AbbVie, Inc.
$22
Taiho Oncology, Inc.
$15
Gilead Sciences, Inc.
$12
Top 3 companies account for 44.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Abraxane · CABOMETYX · Cabometyx · DARZALEX · ERLEADA · GAVRETO · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · KEYTRUDA · KRAZATI · LYNPARZA · Lenvima · Lonsurf · Nerlynx · OPDIVO · Perjeta · REBLOZYL · Rubraca · Stivarga · TAGRISSO · TUKYSA · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · WELIREG · XTANDI · Xofigo · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Greensburg?
Compare hematology & oncology specialists in the Greensburg area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
86
County median income
$72,468
Nearest hospital to ZIP centroid (approximate)
EXCELA HEALTH WESTMORELAND REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Waas is a mixed practice specialist, with above-average Medicare volume (top 20% in PA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Waas experienced with injection, granisetron hydrochloride, 100 mcg?
Based on Medicare claims data, Waas performed 740 injection, granisetron hydrochloride, 100 mcg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Waas receive payments from pharmaceutical companies?
Yes. Waas received a total of $3,505 from 25 companies across 47 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Waas's costs compare to other hematology & oncology specialists in Greensburg?
Waas's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Waas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →